Key facts
- It has raised $3.4M; the latest was Seed Round ($930K) in Oct 2025.
- Notable investors include Grow Ventures Partners, Pompeu Fabra University.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Virtest
- ·The full record, as it builds
Funding rounds
No funding rounds for Virtest are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Virtest
Developer of an online testing platform designed to facilitate remote proctoring and secure digital assessments for academic institutions and certification bodies. The company's platform uses patient-specific imaging, predictive modeling, and anatomical simulation tools to assist in selecting device configurations and assessing procedural risks, enabling interventional cardiologists to improve planning accuracy, reduce complications, and enhance outcomes in cardiovascular interventions.
- Sector
- Healthcare
- HQ
- Barcelona, Spain
- Founded
- 2024
- Employees
- 4
- Website
- virtest.eu/
- Ownership
- Privately Held (backing)
Virtest doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Virtest shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Virtest in its N-PORT filings yet. We sweep new filings monthly.